U.S. flag

An official website of the United States government

NM_000156.6(GAMT):c.467C>A (p.Ala156Asp) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 10, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002282415.1

Allele description [Variation Report for NM_000156.6(GAMT):c.467C>A (p.Ala156Asp)]

NM_000156.6(GAMT):c.467C>A (p.Ala156Asp)

Gene:
GAMT:guanidinoacetate N-methyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.3
Genomic location:
Preferred name:
NM_000156.6(GAMT):c.467C>A (p.Ala156Asp)
HGVS:
  • NC_000019.10:g.1399019G>T
  • NG_009785.1:g.7535C>A
  • NM_000156.6:c.467C>AMANE SELECT
  • NM_138924.3:c.467C>A
  • NP_000147.1:p.Ala156Asp
  • NP_620279.1:p.Ala156Asp
  • NC_000019.9:g.1399018G>T
  • NM_000156.5:c.467C>A
Protein change:
A156D
Links:
dbSNP: rs368221789
NCBI 1000 Genomes Browser:
rs368221789
Molecular consequence:
  • NM_000156.6:c.467C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_138924.3:c.467C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002571922Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 10, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Carrier frequency of guanidinoacetate methyltransferase deficiency in the general population by functional characterization of missense variants in the GAMT gene.

Desroches CL, Patel J, Wang P, Minassian B, Marshall CR, Salomons GS, Mercimek-Mahmutoglu S.

Mol Genet Genomics. 2015 Dec;290(6):2163-71. doi: 10.1007/s00438-015-1067-x. Epub 2015 May 24.

PubMed [citation]
PMID:
26003046

Leigh Syndrome: A Study of 209 Patients at the Beijing Children's Hospital.

Stenton SL, Zou Y, Cheng H, Liu Z, Wang J, Shen D, Jin H, Ding C, Tang X, Sun S, Han H, Ma Y, Zhang W, Jin R, Wang H, Sun D, Lv JL, Prokisch H, Fang F.

Ann Neurol. 2022 Apr;91(4):466-482. doi: 10.1002/ana.26313. Epub 2022 Mar 6.

PubMed [citation]
PMID:
35094435

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002571922.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: GAMT c.467C>A (p.Ala156Asp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.6e-06 in 150994 control chromosomes (gnomAD v3.1, genomes dataset). The variant, c.467C>A, has been reported in the literature in an individual affected with a Leigh syndrome mimicking phenotype (i.e. neurodevelopmental delay) with symmetrical extrapyramidal lesions on MRI, in the absence of mitochondrial dysfunction (Stenton_2022), who also carried second GAMT missense variant (VUS). These data do not allow clear conclusions about variant significance. At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated significantly reduced enzyme activity for the variant protein, however, the variant annotation in the study was somewhat dubious (Desroches_2015). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023